Powder: -20°C for 3 years | In solvent: -80°C for 1 year
5-HT2B antagonist-1 is an orally active 5-HT2B receptor antagonist with an IC 50 of 33.4 nM. It can be used in studies of diseases characterized by 5-HT2B receptor signaling, such as hepatocellular carcinoma, cardiovascular disease or gastrointestinal disease [1] [2].
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
5 mg | 在庫あり | ¥ 15,000 | |||
10 mg | 在庫あり | ¥ 22,500 | |||
25 mg | 在庫あり | ¥ 45,500 | |||
50 mg | 在庫あり | ¥ 75,500 | |||
100 mg | 在庫あり | ¥ 123,500 | |||
500 mg | 在庫あり | ¥ 264,000 | |||
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 16,000 |
説明 | 5-HT2B antagonist-1 is an orally active 5-HT2B receptor antagonist with an IC 50 of 33.4 nM. It can be used in studies of diseases characterized by 5-HT2B receptor signaling, such as hepatocellular carcinoma, cardiovascular disease or gastrointestinal disease [1] [2]. |
In vitro | 5-HT2B antagonist-1 (compound 5g) demonstrates sodium channel binding activity, exhibiting IC50 values between 12.6 to 57.5 μM [1]. Additionally, it (compound 1-e) inhibits 5-HT2B receptor activity by less than 50% at a concentration of 1 μM in CHO-K1 cell lines [3]. |
In vivo | 5-HT2B antagonist-1 (compound 15) (oral gavage, 30 mg/kg) significantly reduces visceral hypersensitivity in irritable bowel syndrome (IBS) rats [2]. |
分子量 | 296.17 |
分子式 | C11H14BrN5 |
CAS No. | 393129-91-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
5-HT2B antagonist-1 393129-91-4 WAY388264A WAY 388264 A Inhibitor inhibitor inhibit